U.S. markets open in 1 hour 36 minutes
  • S&P Futures

    4,167.00
    +13.50 (+0.33%)
     
  • Dow Futures

    33,313.00
    +158.00 (+0.48%)
     
  • Nasdaq Futures

    14,070.25
    +35.25 (+0.25%)
     
  • Russell 2000 Futures

    2,241.60
    +11.00 (+0.49%)
     
  • Crude Oil

    71.68
    +0.04 (+0.06%)
     
  • Gold

    1,783.30
    +14.30 (+0.81%)
     
  • Silver

    26.08
    +0.12 (+0.45%)
     
  • EUR/USD

    1.1891
    +0.0025 (+0.21%)
     
  • 10-Yr Bond

    1.4500
    0.0000 (0.00%)
     
  • Vix

    20.37
    +2.62 (+14.76%)
     
  • GBP/USD

    1.3874
    +0.0065 (+0.47%)
     
  • USD/JPY

    110.1180
    -0.0320 (-0.03%)
     
  • BTC-USD

    32,544.13
    -1,395.26 (-4.11%)
     
  • CMC Crypto 200

    797.24
    -142.71 (-15.18%)
     
  • FTSE 100

    7,010.85
    -6.62 (-0.09%)
     
  • Nikkei 225

    28,010.93
    -953.15 (-3.29%)
     

Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin Boesen; and Chief Financial Officer, Brian W. Adams, will participate in the 39th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021.

The TRHC presentation is scheduled for Thursday, January 14, 2021 at 4:30 p.m. EST. An audio replay of the presentation will be available at https://ir.tabularasahealthcare.com/.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) provides patient medication safety solutions empowering pharmacists and prescribers to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs. TRHC also provides an extensive clinical pharmacy and telepharmacy network across the U.S. Our solutions are trusted by health plans and pharmacies to help drive value-based payment results. For more information, visit TRHC.com.

Tabula Rasa HealthCare Investor Relations Contact:
Frank Sparacino
Senior Vice President, Investor Relations and Corporate Development
fsparacino@trhc.com
T: (312) 451-2157

Tabula Rasa HealthCare Media Contact:
Dianne Semingson
dsemingson@trhc.com
T: (215) 870-0829